|
|
|
Insider
Information: |
Schenkein David P |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
178,178 |
|
Indirect Shares
|
417,826 |
|
|
Direct
Value |
$6,734,804 |
|
|
Indirect Value
|
$17,699,944 |
|
|
Total
Shares |
596,004 |
|
|
Total
Value |
$24,434,748 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-300.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2024-06-13 |
126,242 |
2024-06-13 |
349,854 |
Premium* |
|
Foundation Medicine, Inc. |
FMI |
Director |
2016-06-16 |
23,326 |
2016-06-16 |
10,508 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
|
2020-06-18 |
6,832 |
2014-12-19 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-05-31 |
21,496 |
2024-05-31 |
57,464 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-02 |
282 |
2023-09-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
155 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
Director |
|
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
15,529 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-06-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,975 |
122,854 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2023-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
240 |
240 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
42 |
282 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2024-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,967 |
21,496 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2024-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,388 |
126,242 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-03-10 |
4 |
OE |
$0.30 |
$16,335 |
I/I |
54,000 |
241,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-03-25 |
4 |
OE |
$0.30 |
$7,563 |
I/I |
25,000 |
266,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-09-02 |
4 |
OE |
$0.30 |
$1,966 |
I/I |
6,500 |
259,772 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-09-26 |
4 |
OE |
$0.30 |
$9,075 |
I/I |
30,000 |
283,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2014-10-01 |
4 |
OE |
$0.30 |
$756 |
I/I |
2,500 |
255,772 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-02-27 |
4 |
OE |
$0.30 |
$7,563 |
I/I |
25,000 |
248,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-05-07 |
4 |
OE |
$0.30 |
$3,025 |
I/I |
10,000 |
241,372 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-08-03 |
4 |
OE |
$0.30 |
$231,152 |
I/I |
8,000 |
240,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2016-01-04 |
4 |
OE |
$0.30 |
$3,025 |
I/I |
10,000 |
242,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2016-01-05 |
4 |
OE |
$0.30 |
$3,025 |
I/I |
10,000 |
252,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2016-01-07 |
4 |
OE |
$0.30 |
$6,050 |
I/I |
20,000 |
272,272 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-02-16 |
4 |
OE |
$0.30 |
$1,815 |
D/D |
6,000 |
6,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-04-03 |
4 |
OE |
$0.30 |
$908 |
D/D |
3,000 |
3,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-05-01 |
4 |
OE |
$0.30 |
$908 |
D/D |
3,000 |
3,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-06-06 |
4 |
OE |
$0.30 |
$333 |
D/D |
1,100 |
1,100 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-06-07 |
4 |
OE |
$0.30 |
$575 |
D/D |
1,900 |
1,900 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-07-03 |
4 |
OE |
$0.30 |
$908 |
D/D |
3,000 |
3,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-08-01 |
4 |
OE |
$0.30 |
$908 |
D/D |
3,000 |
3,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-08-02 |
4 |
OE |
$0.30 |
$7,260 |
D/D |
24,000 |
24,000 |
0 |
- |
|
155 Records found
|
|
Page 2 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|